Skip to main content

Table 1 The correlation of clinical and dosimetric parameters with RIBPN

From: Dosimetric analysis of the brachial plexus among patients with breast cancer treated with post-mastectomy radiotherapy to the ipsilateral supraclavicular area: report of 3 cases of radiation-induced brachial plexus neuropathy

Characteristic

Group 1

Group 2

p

Age (y)

49 (34–63)

36 (31–43)

0.056

Height (m)

1.58 ± 0.05

1.51 ± 0.03

0.073

Weight (kg)

56.13 ± 7.38

47.60 ± 1.83

0.090

BMI (kg/m2)

22.52 ± 2.44

20.86 ± 0.28

0.259

Number of RLNs (n)

23.42 ± 6.51

34.00 ± 10.15

0.044

Dmean (Gy)

44.39 ± 4.13

47.03 ± 1.54

0.286

Dmax (Gy)

56.16 ± 2.58

59.33 ± 0.83

0.111

V40 (%)

79.90 ± 10.74

87.55 ± 2.91

0.202

V45 (%)

68.22 ± 12.63

76.29 ± 3.85

0.271

V50 (%)

49.25 ± 16.58

58.97 ± 3.41

0.320

V52.5 (%)

28.52 ± 18.98

32.12 ± 3.70

0.740

V55 (%)

6.08 ± 10.36

5.81 ± 1.51

0.963

  1. BMI: body mass index; RLNs: removed lymph nodes.
  2. Vn indicates the volume of the BP receiving n Gy.